 Ampio Pharmaceuticals, Inc. NYSE American: AMPE the Company or Ampio, is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the Company is actively working on the development of therapies for patients infected with the SARS-CoV-2 virus COVID-19. 